• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. Jun 1994; 62(6): 2478–2482.
PMCID: PMC186534

Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.

Abstract

Staphylococcus aureus produces a variety of proteins, including alpha-toxin and protein A, that could contribute to corneal tissue damage during keratitis. We examined corneal infections produced by intrastromal injection of four S. aureus strains--three isogenic mutants, one lacking alpha-toxin (Hly- Spa+), one lacking protein A (Hly+ Spa-), and one lacking both alpha-toxin and protein A (Hly- Spa-), and the wild type (Hly+ Spa+)--in a rabbit model of experimental keratitis. Rabbit corneas were injected intrastromally with 100 CFU of one of the four strains, and the eyes were examined by slit lamp biomicroscopy over a 25-h period. Corneal homogenates were used for determination of CFU and neutrophil myeloperoxidase activity at 5-h intervals. All strains had the same logarithmic growth curve from 0 to 10 h postinfection, after which CFU remained constant at 10(7) CFU per cornea. By 15 h postinfection, slit lamp examination scores were significantly higher for eyes infected with Hly+ strains than for Hly(-)-infected eyes. At this time, distinct epithelial erosions were seen in Hly(+)-infected eyes but not in Hly(-)-infected eyes. Myeloperoxidase activity was significantly greater for Hly(+)-infected corneas than for Hly(-)-infected corneas at both 20 and 25 h postinfection. Spa(+)- and Spa(-)-infected eyes showed no differences in slit lamp examination scores or myeloperoxidase activities. These results suggest that alpha-toxin, but not protein A, is a major virulence factor in staphylococcal keratitis, mediating the destruction of corneal tissue in eyes infected with this bacterial pathogen.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bhakdi S, Tranum-Jensen J. Damage to mammalian cells by proteins that form transmembrane pores. Rev Physiol Biochem Pharmacol. 1987;107:147–223. [PubMed]
  • Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982 Mar;78(3):206–209. [PubMed]
  • Bramley AJ, Patel AH, O'Reilly M, Foster R, Foster TJ. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun. 1989 Aug;57(8):2489–2494. [PMC free article] [PubMed]
  • Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1033–1037. [PubMed]
  • Callegan MC, Hill JM, Insler MS, Hobden JA, O'Callaghan RJ. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Curr Eye Res. 1992 Nov;11(11):1111–1119. [PubMed]
  • Callegan MC, Hobden JA, Hill JM, Insler MS, O'Callaghan RJ. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3017–3023. [PubMed]
  • Chusid MJ, Davis SD. Polymorphonuclear leukocyte kinetics in experimentally induced keratitis. Arch Ophthalmol. 1985 Feb;103(2):270–274. [PubMed]
  • Forsgren A, Sjöquist J. "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol. 1966 Dec;97(6):822–827. [PubMed]
  • Gustafson GT, Stålenheim G, Forsgren A, Sjöquist J. "Protein A" from Staphylococcus aureus. IV. Production of anaphylaxis-like cutaneous and systemic reactions in non-immunized guinea-pigs. J Immunol. 1968 Mar;100(3):530–534. [PubMed]
  • Haraldsson I, Jonsson P. Histopathology and pathogenesis of mouse mastitis induced with Staphylococcus aureus mutants. J Comp Pathol. 1984 Apr;94(2):183–196. [PubMed]
  • Harshman S, Boquet P, Duflot E, Alouf JE, Montecucco C, Papini E. Staphylococcal alpha-toxin: a study of membrane penetration and pore formation. J Biol Chem. 1989 Sep 5;264(25):14978–14984. [PubMed]
  • Hazlett LD, Zucker M, Berk RS. Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice. Ophthalmic Res. 1992;24(1):32–39. [PubMed]
  • Heczko PB, Grov A, Oeding P. In vivo reactions of staphylococcal antigens. 1. Hypersensitivity to protein A. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Dec;81(6):731–740. [PubMed]
  • Johnson MK, Hobden JA, Hagenah M, O'Callaghan RJ, Hill JM, Chen S. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res. 1990 Nov;9(11):1107–1114. [PubMed]
  • Jonsson P, Lindberg M, Haraldsson I, Wadström T. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect Immun. 1985 Sep;49(3):765–769. [PMC free article] [PubMed]
  • Kupferman A, Leibowitz HM. Quantitation of bacterial infection and antibiotic effect in the cornea. Arch Ophthalmol. 1976 Nov;94(11):1981–1984. [PubMed]
  • Kupferman A, Leibowitz HM. Topical antibiotic therapy of staphylococcal keratitis. Arch Ophthalmol. 1977 Sep;95(9):1634–1637. [PubMed]
  • Limberg MB. A review of bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol. 1991 Oct;112(4 Suppl):2S–9S. [PubMed]
  • Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967 Sep;33(1):155–166. [PubMed]
  • O'Reilly M, de Azavedo JC, Kennedy S, Foster TJ. Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. Microb Pathog. 1986 Apr;1(2):125–138. [PubMed]
  • Patel AH, Nowlan P, Weavers ED, Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun. 1987 Dec;55(12):3103–3110. [PMC free article] [PubMed]
  • Thelestam M, Blomqvist L. Staphylococcal alpha toxin--recent advances. Toxicon. 1988;26(1):55–65. [PubMed]
  • Williams RN, Paterson CA, Eakins KE, Bhattacherjee P. Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. Curr Eye Res. 1982;2(7):465–470. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...